OptimizeRx Corp (NAS:OPRX)
$ 6.265 -0.005 (-0.08%) Market Cap: 114.79 Mil Enterprise Value: 138.11 Mil PE Ratio: 0 PB Ratio: 0.95 GF Score: 71/100

Q1 2022 OPTIMIZERx Corp Earnings Call Transcript

May 04, 2022 / 08:30PM GMT
Release Date Price: $29.97 (+3.88%)
Operator

Greetings. Welcome to OptimizeRx Corporation's First Quarter 2022 Conference Call. (Operator Instructions) Please note this conference is being recorded.

I will now turn the conference over to Will Febbo. Thank you. You may begin.

William J. Febbo
OptimizeRx Corporation - CEO & Director

Thank you, operator. Hi, everyone. Good afternoon, and thank you for joining OptimizeRx for our first call of the new fiscal year. Our mission remains to stay ahead of health care's rapidly evolving digital transformation, building a more informed and empowered health care community by developing new technology solutions that help people start and stay on life impacting therapies.

In executing our operating strategy, we have the privilege of serving doctors and patients at the point of care, but also enabling our pharma clients digital engagement and connectivity at a time when the need could not be greater. Our technology solutions and market-leading HCP network are a pragmatic choice for our clients, who are looking for strong digital connection to

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot